RENEO PHARMACEUTICALS INC's ticker is RPHM and the CUSIP is 75974E103. A total of 39 filers reported holding RENEO PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $457,669 | +15.6% | 60,101 | -0.4% | 0.00% | 0.0% |
Q2 2023 | $396,001 | -15.5% | 60,366 | -23.0% | 0.00% | 0.0% |
Q1 2023 | $468,772 | +151.5% | 78,390 | -2.0% | 0.00% | 0.0% |
Q4 2022 | $186,400 | +84.6% | 80,000 | +166.7% | 0.00% | – |
Q3 2022 | $101,000 | +26.2% | 30,000 | 0.0% | 0.00% | – |
Q2 2022 | $80,000 | +60.0% | 30,000 | +76.5% | 0.00% | – |
Q1 2022 | $50,000 | -65.5% | 17,000 | 0.0% | 0.00% | – |
Q4 2021 | $145,000 | +14.2% | 17,000 | 0.0% | 0.00% | – |
Q3 2021 | $127,000 | -20.1% | 17,000 | 0.0% | 0.00% | – |
Q2 2021 | $159,000 | – | 17,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RiverVest Venture Management LLC | 2,409,220 | $8,071,000 | 9.37% |
Abingworth LLP | 2,073,957 | $6,948,000 | 2.38% |
Aisling Capital Management LP | 886,075 | $2,968,000 | 1.97% |
NEA Management Company, LLC | 4,786,921 | $16,036,000 | 0.80% |
Novo Holdings A/S | 3,430,377 | $11,492,000 | 0.55% |
Ikarian Capital, LLC | 155,819 | $521,000 | 0.10% |
Rock Springs Capital Management LP | 1,143,185 | $3,830,000 | 0.10% |
Ergoteles LLC | 37,640 | $126,000 | 0.00% |
MAI Capital Management | 63,210 | $212,000 | 0.00% |
RBF Capital, LLC | 14,536 | $49,000 | 0.00% |